1. Home
  2. AERO vs BHVN Comparison

AERO vs BHVN Comparison

Compare AERO & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grupo Aeromexico S.A.B.

AERO

Grupo Aeromexico S.A.B.

HOLD

Current Price

$15.95

Market Cap

2.2B

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$13.94

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AERO
BHVN
Founded
1934
2013
Country
Mexico
United States
Employees
17068
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.3B
IPO Year
2023
2022

Fundamental Metrics

Financial Performance
Metric
AERO
BHVN
Price
$15.95
$13.94
Analyst Decision
Strong Buy
Buy
Analyst Count
7
14
Target Price
$28.57
$29.08
AVG Volume (30 Days)
346.1K
3.8M
Earning Date
04-21-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.08
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.85
N/A
Revenue Next Year
$4.57
N/A
P/E Ratio
$7.95
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.26
$7.48
52 Week High
$23.05
$18.57

Technical Indicators

Market Signals
Indicator
AERO
BHVN
Relative Strength Index (RSI) 58.63 49.87
Support Level $15.85 $13.56
Resistance Level $16.67 $15.42
Average True Range (ATR) 0.62 1.05
MACD 0.10 -0.11
Stochastic Oscillator 92.15 45.03

Price Performance

Historical Comparison
AERO
BHVN

About AERO Grupo Aeromexico S.A.B.

Grupo Aeromexico SAB de CV engages in providing air transport services for passengers, goods, and cargo, as well as loyalty program services, training and management services, franchise systems commercialization, and the management of investment in shares. Its services include passenger and cargo transportation, the Club Premier loyalty program, training, charter services, and other aviation-related activities. The company operates through a single operating segment, air transportation, and its geographical presence includes both domestic and international markets, with the majority of revenue coming from the international market.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: